RELAFEN Trademark

Trademark Overview

On Wednesday, November 29, 2017, a trademark application was filed for RELAFEN with the United States Patent and Trademark Office. The USPTO has given the RELAFEN trademark a serial number of 87702292. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Argent Development Group, LLC. The RELAFEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis
relafen

General Information

Serial Number87702292
Word MarkRELAFEN
Filing DateWednesday, November 29, 2017
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6048100
Registration DateTuesday, May 5, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 11, 2017
Primary Code005
First Use Anywhere DateWednesday, October 30, 2019
First Use In Commerce DateWednesday, October 30, 2019

Trademark Owner History

Party NameArgent Development Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040
Party NameArgent Development Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040
Party NameArgent Development Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040

Trademark Events

Event DateEvent Description
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, April 1, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 31, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 11, 2020ASSIGNED TO LIE
Thursday, March 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 4, 2020NON-FINAL ACTION E-MAILED
Tuesday, February 4, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 14, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, December 30, 2019USE AMENDMENT FILED
Thursday, January 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 30, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, November 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2019EXTENSION 3 GRANTED
Friday, November 8, 2019EXTENSION 3 FILED
Friday, November 8, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 12, 2019EXTENSION 2 GRANTED
Sunday, May 12, 2019EXTENSION 2 FILED
Sunday, May 12, 2019TEAS EXTENSION RECEIVED
Wednesday, November 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 5, 2018EXTENSION 1 GRANTED
Monday, November 5, 2018EXTENSION 1 FILED
Monday, November 5, 2018TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 7, 2018ASSIGNED TO EXAMINER
Monday, December 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 2, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

relafen treatment rheumatoid arthritis respect osteoarthritis pain preparations inflammation pharmaceutical particularly